Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients

Asian Journal of Transfusion Science

Volumn 3, Issue 1, 2009, Pages 14-17

  Elghannam, Doaa ^a,b   Aly, Rabab ^a   Goda, Enas ^a   Eltoraby, Ehab ^a   Farag, Raghda ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

Anti HBc; Hemodialysis patients; Hepatitis B infection

Indexed keywords

EID: 80053641306     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.45256     Document Type: Article

References (35)

1. Shaaban FA, Hassanin AI, Samy SM, Salama SI, Said ZN. Said Long-term immunity to hepatitis B among a sample of fully vaccinated children in Cairo, Egypt. East Mediterr Health J 2007;13:750-7.
2. Crovari P. Epidemiology of hepatitis B virus infection in Italy. Viral Hepatitis 2003;11:7-8.
3. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 1995;13:29-60.
4. Alvarez-Munoz T, Bustamante-Calvillo E, Martinez- Garcia C, Morena-Altamirano L, Guiscafre- Gallardo H, Guiscafre JP, et al Seroepidemiology of the hepatitis B and delta in the southeast of Chiapas, Mexico. Arch Investig Med 1989;20:189-95.
5. Balderas-Renteria LE, Munoz-Espinosa MA, Dector-Carrillo FJ, Martinez-Martinez HA, Barrera-Saldaña HA. Detection of hepatitis B virus in seropositive and seronegative patients with chronic liver disease using DNA amplification by PCR. Arch Med Res 2002;33:566-71.
6. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002;2:479-86.
7. Giarcia - Montalvo BM, Farfar-Ale JA, Acosta Vidna KY, Puerto-Marzano FL Hepatitis B Virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med 2005;15:371-8.
8. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997;4:11-20.
9. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatol-ogy 2001;34:194-203.
10. Conjeevaram H, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001; 34:204-6.
11. Maynard. Vaccine B 1990;18-23 volume no missing
12. El Khouri M, dos Santos VA. Hepatitis B: Epidemiological, immu-nological, and serological considerations emphasizing mutation. Rev Hosp Clin Fac Med Sao Paulo 2004;59:216-24.
13. Di Bisceglie AM. Hepatitis C. Lancet 1998;351:351-5.
14. Saxena AK, Panhotra BR. The prevalence of nasal carriage of staphy-lococcus areus and associated vascular access releated septicemia among patients on heodialysis in AL-Hasa Region Of Saudi Arabia. Saudi J Kidney Dis Transpl 2003;14:30-8.
15. Kishi Y, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Makuuchi M. New-onset diabetes mellitus after living donor liver transplantation: Possible association with hepatitis C. Transplant Proc 2006;38:2989-92.
16. Girndt M, Kohler H. Hepatitis B virus infection in hemodialysis patients. Semin Nephrol 2002;22:340-50.
17. Leung CB, Ho YW, Chau KF, Choy BY, Tsang WK, Lui S; et al Renal replacement therapy for chronic hepatitis B carriers: A subgroup analysis from the Hong Kong Renal Registry 1995-1999. Hong Kong J Nephrol 2000;2:104-9.
18. Gohar SA, Khalil RY, Elaish NM, Ahmed MS. Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients. J Egypt Public Health Assoc 1995;70:465-84.
19. Cendoroglo Neto M, Manzano SI, Canziani MF, Silva AE, Cirenza LF, Sesso Rde C, et al Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 1995;19:251-5.
20. Cao YL, Wang SK, Zhu ZM. Hepatitis B viral infection in maintenance hemodialysis patients: A three year follow-up. World J Gastroenterol 2007;13:6037-40.
21. Afifi A, Karim MA. Renal replacement therapy in Egypt: First annual report of the Egyptian Society of Nephrology, 1996. East Mediterr Health J 1999;5:1023-9.
22. Lopez L, Lopez P, Arago A, Rodriguez I, Lopez J, Lima E, et al Risk Factors for hepatitis B and C in multi transude patients in Uruguay. J Clin Virol 2005:34:S69-74.
23. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, et al Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail 2006;28:729-35.
24. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV infected patients positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 1998;17:6-13.
25. Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific a-determinant or hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000;81:1165-74.
26. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 2001;64:312-9.
27. El-Zaatari M, Kazma H, Naboulsi-Majzoub M, Haidar M, Ramlawi F, Mahfoud Z, et al Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications. J Hosp Infect 2007;66:278-82.
28. Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in Indian reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 2003;43:1442-8.
29. Gutierrez C, Devesa M, Loureiro CL, Leon G, Liprandi F, Pujol FH. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. J Med Virol 2004;73:200-7.
30. Larsen J, Hetland G, Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1999;30:431:43
31. Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, et al Posttransfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol 1996;25:639-43.
32. El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, et al Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med 2008;18:55-61.
33. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000;18:S17-9.
34. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, et al Serological pattern'anti-HBc alone': Report on a workshop. J Med Virol 2000;62:450-45.
35. Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine 2004;28:3963-7.